-
My Account
In App
My Account
BSE Live
Dec 08, 16:01Prev. Close
69.04
Open Price
70.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 08, 15:55Prev. Close
68.97
Open Price
69.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
66.74 (107)
| Profit & Loss account of Krebs Biochemicals & Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 43.31 | 50.42 | 26.64 | 52.94 | 38.61 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 43.31 | 50.42 | 26.64 | 52.94 | 38.61 | |
| Total Operating Revenues | 43.31 | 50.42 | 52.13 | 59.70 | 53.70 | |
| Other Income | 0.71 | 0.45 | 0.62 | 1.16 | 0.62 | |
| Total Revenue | 44.02 | 50.87 | 52.75 | 60.86 | 54.32 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2.49 | 5.43 | 15.36 | 46.18 | 25.62 | |
| Purchase Of Stock-In Trade | 0.04 | 0.09 | 4.44 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 33.06 | 26.28 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.03 | 1.07 | 5.87 | -5.54 | 0.32 | |
| Employee Benefit Expenses | 16.60 | 16.47 | 15.84 | 15.30 | 15.83 | |
| Finance Costs | 5.91 | 4.69 | 2.97 | 5.39 | 6.28 | |
| Depreciation And Amortisation Expenses | 6.69 | 6.77 | 6.56 | 6.30 | 5.12 | |
| Other Expenses | 36.19 | 36.08 | 26.39 | 4.70 | 3.22 | |
| Total Expenses | 70.94 | 70.60 | 77.45 | 105.39 | 82.68 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -26.92 | -19.73 | -24.69 | -44.53 | -28.36 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -26.92 | -19.73 | -24.69 | -44.53 | -28.36 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax For Earlier Years | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 | |
| Profit/Loss From Continuing Operations | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 | |
| Profit/Loss For The Period | -26.94 | -19.73 | -24.69 | -44.53 | -28.36 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 | |
| Diluted EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.11.2025
Krebs Biochem Standalone September 2025 Net Sales at Rs 4.17 crore, down 67.58% Y-o-Y
22.08.2025
Krebs Biochem Standalone June 2025 Net Sales at Rs 5.48 crore, down 57.48% Y-o-Y
05.02.2025
Krebs Biochem Standalone December 2024 Net Sales at Rs 11.47 crore, down 11.64% Y-o-Y
12.11.2024
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67% Y-o-Y
